Gastric Mucosal Blood Flow and Neutrophil Activation in Aspirin-Induced Gastric Mucosal Damage in Man

References

• Lanza F L. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin and other nonsteroidal antiinflammatory agents. Am J Med 1984; 77: 19–24
   PubMed Web of Science ®Google Scholar
• Caruso I, Bianchi-Porro G. Gastroscopic evaluation of antiinflammatory agents. Br Med J 1980; 280: 75–8
   PubMed Web of Science ®Google Scholar
• Ivey K J. Mechanisms of NSAID-induced gastric damage; actions of therapeutic agents. Am J Med 1988; 84(Suppl 2A)41–8
   PubMedGoogle Scholar
• Whittle B JR. The potentiation of taurocholate induced rat gastric erosions following parenteral administration of cyclo-oxygenase inhibitors. Br J Pharmacol 1983; 80: 545–51
   PubMed Web of Science ®Google Scholar
• Kitahora T, Guth P H. Effect of aspirin plus hydrochloric acid in the gastric mucosal microcirculation. Gastroenterology 1987; 93: 810–7
   PubMed Web of Science ®Google Scholar
• Sandor Z, Szabo S. Pharmacologic approaches and pathogenic basis for NSAID gastropathy, prevention and treatment. Proc Gastroenterol 1991; 15: 30–43
   Google Scholar
• Hiroshi Asako Kubes P, Wallace I L, Wolf R E, Granger D N. Modulation of leukocyte adhesion in rat mesenteric venules by aspirin and salicylate. Gastroenterology 1992; 103: 146–52
   PubMedGoogle Scholar
• Wallace I L, Keenan C M, Granger D N. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil dependent mechanism. Am J Physiol 1990; 259: G462–7
   PubMed Web of Science ®Google Scholar
• McCarthy D M. Pathogenic mechanisms of gastroduodenal injury: nonsteroidal anti-inflammatory drugs. Gastroenterology 1991; 7: 876–80
   Google Scholar
• Hattori R, Hamilton K K, Fugare R D, McEvert R P, Sims P J. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989; 264: 7768–71
   PubMed Web of Science ®Google Scholar
• Saltzman A. Fluorometric method for the estimation of salicylate in blood. J Biol Chem 1948; 174: 399–404
   PubMed Web of Science ®Google Scholar
• Jungi T W, Spycher M O, Nydegger U E, Barandum S. Platelet-leukocyte interaction: selective binding of thrombin stimulated platelets of human monocytes, polymorphonuclear leukocytes and related cell lanes. Blood 1986; 77: 629–35
   Google Scholar
• Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one cen-trifugation and sedimentation at 1 g. J Clin Lab Invest 1968; 21(Suppl 97)77–82
   PubMed Web of Science ®Google Scholar
• Hsu-Lin S C, Berman C L, Furie B C, August D, Furie B. A platelet membrane protein expressed during platelet activation. J Biol Chem 1984; 259: 9121–6
   PubMed Web of Science ®Google Scholar
• Konturek S J, Kwiecien N, Obtulowicz W, Polanski M, Kopp B, Oleksy J. Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man. Gut 1981; 24: 89–93
   Web of Science ®Google Scholar
• Lanza F L. A review of mucosal protection by synthetic prostaglandin E analogues against injury by nonsteroidal anti-inflammatory drugs. Scand J Gastroenterol 1989; 24(Suppl 163)36–43
   Web of Science ®Google Scholar
• Brzozowski T, Majka J, Konturek S J. Gastroprotective and ulcer-healing activities of a new H2 receptor antagonist: ebroti-dine. Digestion 1992; 51: 27–36
   PubMed Web of Science ®Google Scholar
• Kitchingman G, Prichard P J, Daneshmend T K, Walt R P, Hawkey C J. Enhanced gastric mucosal bleeding with low dose aspirin and its reduction by ranitidine. Br J Clin Pharmacol 1988; 28: 581–5
   Google Scholar
• Hawkey C J, Simpson G, Somerville K W. Reduction by enprostil of aspirin induced bleeding from the human gastric mucosa. Am J Med 1986; 80(2A)50–2
   PubMedGoogle Scholar
• Hagel H J, Wild H, Ruppin H, Kachel G, Domschke W. Gastrale Cytoprotektion durch Antazida und Schleimhautadaptation an Acetylsalicylsäure. Gastroenterohepatologie 1984; 4: 2–8
   Google Scholar
• Pierson R N, Holt P R, Watson R M, Keatling R R. Aspirin and gastrointestinal bleeding: chromate51 blood loss studies. Am J Med 1961; 31: 259–65
   PubMed Web of Science ®Google Scholar
• Main I HM, Whittle B JR. Investigation of the vasodilator and antisecretory role of prostaglandins in the rat gastric mucosa by use of nonsteroidal anti-inflammatory drugs. Br J Pharmacol 1975; 53: 217–24
   PubMed Web of Science ®Google Scholar
• Kaufman G L, Jr, Aures D, Grossman M I. Indomethacin decreases basal gastric blood flow. Gastroenterology 1979; 76: 1165–73
   Google Scholar
• Ashley S W, Sonnenschein L A, Cheung L Y. Focal gastric mucosal blood flow at the site of aspirin-induced ulceration. Am J Surg 1985; 149: 53–9
   PubMed Web of Science ®Google Scholar
• Shorrock C J, Rees W DW. Mucosal adaptation to indomethacin induced gastric damage in man–studies on morphology, blood flow, and prostaglandin metabolism. Gut 1992; 33: 164–9
   PubMed Web of Science ®Google Scholar
• Konturek S J, Kwiecien N, Obtulowicz W. Effect of carprofen and indomethacin on gastric function, mucosal integrity and generation of prostaglandin in man. Hepatogastroenterology 1982; 29: 267–73
   PubMedGoogle Scholar
• Tarnawski A, Stachura J, Gergely H, Hollander D. Gastric mucosal epithelium; a major target for aspirin-induced injury and arachidonic acid protection, and ultrastructural analysis in the rat. Eur J Chem Invest 1990; 20: 432–40
   PubMedGoogle Scholar
• Graham D Y, Smith J L, Dobbs S M. Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci 1983; 28: 1–6
   PubMed Web of Science ®Google Scholar
• O'Laughin J C, Hoftrezer J W, Ivey K J. Effect of aspirin in the human stomach in normals: endoscopic comparison of damage produced one hour, 24 hours, and 2 weeks after administration. Scand J Gastroenterol 1981; 16(Suppl 67)211–14
   Google Scholar
• Levis S, Goodland R A, Lee C Y, Walport M J, Wright N A, Hodgson H JE. Effect of nonsteroidal anti-inflammatory drugs and misoprostol on gastrointestinal epithelial proliferation in arthritis. Gastroenterology 1992; 102: 1605–11
   PubMedGoogle Scholar
• Peskar B M, Respondek W, Miiller K M, Peskar B A. Role of nitric oxide in capsaicin-induced gastroprotection. Pharmacology 1991; 198: 113–8
   Google Scholar
• Konturek S J, Brzozowski T, Majka J, Czarnobilski K. Role of nitric oxide and prostaglandins in sucralfate induced gastroprotection. Eur J Pharmacol 1992; 211: 277–9
   PubMedGoogle Scholar
• Radomski M W, Palmer R MJ, Moncada S. Endogenous nitric oxide inhibits human adhesion to human vascular endothelium. Lancet 1987; 2: 1057–8
   PubMed Web of Science ®Google Scholar
• Wallace J L. Non-steroidal anti-inflammatory drug gastropathy and cytoprotection. Pathogenesis and mechanisms re-examined. Scand J Gastroenterol 1992; 27(Suppl 192)3–8
   Web of Science ®Google Scholar
• Kubes P, Suzuki M, Granger D N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651–5
   PubMed Web of Science ®Google Scholar
• Lowenstein Ch J, Snyder S H. Nitric oxide, a novel biologic messenger. Cell 1992; 70: 705–7
   PubMed Web of Science ®Google Scholar